Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Univercells is a Belgian biotechnology company dedicated to making biologics accessible and affordable globally through innovative bioprocessing technologies. The company focuses on bioprocessing intensification, utilizing its proprietary platforms to reduce the footprint and cost of manufacturing vaccines, viral vectors, and monoclonal antibodies. Through its various subsidiaries and affiliates, such as Quantoom Biosciences and N-BIOTEK, Univercells provides end-to-end solutions ranging from discovery to large-scale production. Their mission is to enable biologics for all by supporting local manufacturing in low- and middle-income countries. The company operates as a group of specialized entities, including the CDMO Exothera, to address different segments of the biopharmaceutical value chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Univercells.